![Ventral view of the three parts of the colon. Cranial side is at the... | Download Scientific Diagram Ventral view of the three parts of the colon. Cranial side is at the... | Download Scientific Diagram](https://www.researchgate.net/profile/Alejandro-Bielli-2/publication/23666617/figure/fig5/AS:601662032982026@1520458815378/Ventral-view-of-the-three-parts-of-the-colon-Cranial-side-is-at-the-left-of-the-picture_Q320.jpg)
Ventral view of the three parts of the colon. Cranial side is at the... | Download Scientific Diagram
![Pharmaceutics | Free Full-Text | A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer Pharmaceutics | Free Full-Text | A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-02020/article_deploy/html/images/pharmaceutics-15-02020-g003.png?1690358536)
Pharmaceutics | Free Full-Text | A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer
![An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer | Journal of Experimental & Clinical Cancer Research | Full Text An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-023-02784-0/MediaObjects/13046_2023_2784_Fig3_HTML.png)
An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer | Journal of Experimental & Clinical Cancer Research | Full Text
![Does signet ring cell carcinoma component signify worse outcomes for patients with colorectal cancer? - ScienceDirect Does signet ring cell carcinoma component signify worse outcomes for patients with colorectal cancer? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1015958420300968-gr2.jpg)
Does signet ring cell carcinoma component signify worse outcomes for patients with colorectal cancer? - ScienceDirect
![Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer | Science Translational Medicine Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aac7433/asset/ecd930b2-f740-40c5-b34e-daad9080b314/assets/graphic/7-314ra186-f1.jpeg)
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer | Science Translational Medicine
![Weakly supervised and transfer learning for adenocarcinoma classification in transurethral resection of the prostate whole slide images | medRxiv Weakly supervised and transfer learning for adenocarcinoma classification in transurethral resection of the prostate whole slide images | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/04/21/2022.04.20.22274062/F3.large.jpg)
Weakly supervised and transfer learning for adenocarcinoma classification in transurethral resection of the prostate whole slide images | medRxiv
![Pharmaceutics | Free Full-Text | A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer Pharmaceutics | Free Full-Text | A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-02020/article_deploy/html/images/pharmaceutics-15-02020-g0A3.png?1690358520)
Pharmaceutics | Free Full-Text | A Novel Dual-Payload ADC for the Treatment of HER2+ Breast and Colon Cancer
![Overexpression of the transcribed ultraconserved region Uc.138 accelerates colon cancer progression | Scientific Reports Overexpression of the transcribed ultraconserved region Uc.138 accelerates colon cancer progression | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-88123-9/MediaObjects/41598_2021_88123_Fig1_HTML.png)
Overexpression of the transcribed ultraconserved region Uc.138 accelerates colon cancer progression | Scientific Reports
![Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates | Molecular Pharmaceutics Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.8b00275/asset/images/medium/mp-2018-00275e_0002.gif)
Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates | Molecular Pharmaceutics
![Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer Immunotherapy | Journal of Medicinal Chemistry Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer Immunotherapy | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00961/asset/images/large/jm1c00961_0011.jpeg)
Immune Modulating Antibody–Drug Conjugate (IM-ADC) for Cancer Immunotherapy | Journal of Medicinal Chemistry
![Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer | Science Translational Medicine Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aac7433/asset/2d9b6eec-e4a6-4bc4-9e9b-8833016b573c/assets/graphic/7-314ra186-f4.jpeg)